On March 10, 2017, the General Office of the China Banking Regulatory Commission ("CBRC") promulgated the Circular on Carrying on Certain Businesses...
With cross-border deals making up 80% of surveyed Australian M&A ‘mega deals’ in 2016, international investors see Australia as a favourable place to...
KWM has been recognised as ‘Best Law Firm (revenue > $200M)’ for the second consecutive year at the AFR's Client Choice Awards for 2017.
KWM represented the Government of the Kyrgyz Republic to successfully overturn the US$16.5 million UNCITRAL award
Our Digital Intelligence hub provides you with a range of resources to stay ahead of regulatory changes and uncover the latest market opportunities.
King & Wood Mallesons secured a major victory for a high profile Kuwaiti developer, owned by Kuwaiti Royals, in a USD 100 million construction arbitration case seated in Doha, Qatar.
KWM is pleased to confirm that it has established a new business to maintain a strategic presence in the UK, Europe & the Middle East.
King & Wood Mallesons has elected Frankfurt partner Michael Cziesla as its new EUME Senior Partner with immediate effect for a term of three years.
UBS’ Oncology Impact Fund is the first of its kind in the healthcare sector and the largest global impact investing opportunity that’s come to market to date.